graphy and echocardiography which revealed no abnormalities. He received 13 Gy total body irradiation and CY We report a case of pneumococcal pericarditis in a 13-(2 × 60 mg/kg) as conditioning therapy. GVHD prophylaxis year-old boy following allogeneic BMT from an HLAconsisted of CsA, short-term MTX (three doses on days identical unrelated donor. The post-transplant course +1, +3 and +6 following BMT) and prednisolone. There was complicated by chronic GVHD which led to reinstiwere no manifestations of acute GVHD. On day +145 the tution of immunosuppressive therapy. Eight months patient was treated with a 14-day course of foscarnet for after BMT the patient developed pericarditis with car-CMV infection. On day +224, after complete withdrawal diac tamponade, and Streptococcus pneumoniae was isoof immunosuppressive therapy, he presented with clinical lated in the pericardiocentesis fluid. This is the first signs of chronic GVHD involving skin, oral mucosa and reported case of pneumococcal pericarditis after BMT.
Discussion
a week schedule was ineffective in our patient. Some authors recommend this schedule to minimize the risk of both bacterial and Pneumocystis infection in patients with Most pericardial effusions occurring after BMT are not chronic GVHD, 11 and others recommend daily adminisinfective and are related to the cardiotoxic effects of contration for adequate coverage of bacteria. 2 In our patient, ditioning therapy, particularly cyclophosphamide. 3, 4 This breakthrough infection could have occurred because of an complication usually happens in the first 30 days after BMT inadequate dose schedule or because of in vitro resistance, and may be associated with acute cardiomyopathy and fatal since in vitro susceptibility to the cotrimoxazole was not heart failure. 4 In the late post-transplantation period after assessed. Intravenous immunoglobulin supplementation is allogeneic BMT the occurrence of large and sterile also a possible option for these patients, although its utility effusions involving pericardial, pleural and/or peritoneal and cost-effectiveness has not yet been established. these patients and occasionally gives rise to fever of
